| Literature DB >> 33905661 |
Keerthana Rajes1, Karolina A Walker1, Sabrina Hadam2, Fatemeh Zabihi1,2, Jumana Ibrahim-Bacha1, Gregor Germer1, Piotr Patoka1, Bernhard Wassermann1, Fiorenza Rancan2, Eckart Rühl1, Annika Vogt2, Rainer Haag1.
Abstract
A synthetic route for oxidation-sensitive core-multishell (osCMS) nanocarriers was established, and their drug loading and release properties were analyzed based on their structural variations. The nanocarriers showed a drug loading of 0.3-3 wt % for the anti-inflammatory drugs rapamycin and dexamethasone and the photosensitizer meso-tetra-hydroxyphenyl-porphyrin (mTHPP). Oxidative processes of the nanocarriers were probed in vitro by hydrogen peroxide, and the degradation products were identified by infrared spectroscopy supported by ab initio calculations, yielding mechanistic details on the chemical changes occurring in redox-sensitive nanocarriers. Oxidation-triggered drug release of the model drug Nile Red measured and assessed by time-dependent fluorescence spectroscopy showed a release of up to 80% within 24 h. The drug delivery capacity of the new osCMS nanocarriers was tested in ex vivo human skin with and without pretreatments to induce local oxidative stress. It was found that the delivery of mTHPP was selectively enhanced in skin under oxidative stress. The number and position of the thioether groups influenced the physicochemical as well as drug delivery properties of the carriers.Entities:
Keywords: AFM-IR; CMS nanocarriers; Nile Red; anti-inflammatory drugs; dexamethasone; mTHPP; oxidation; rapamycin; redox; skin penetration; stimuli-triggered; thioether
Year: 2021 PMID: 33905661 DOI: 10.1021/acsbiomaterials.0c01771
Source DB: PubMed Journal: ACS Biomater Sci Eng ISSN: 2373-9878